Cardinal Health, Inc. (NYSE:CAH) Receives Average Rating of “Moderate Buy” from Analysts

Cardinal Health, Inc. (NYSE:CAHGet Free Report) has received a consensus recommendation of “Moderate Buy” from the sixteen analysts that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $136.87.

CAH has been the topic of a number of recent analyst reports. Barclays raised their target price on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. Mizuho started coverage on Cardinal Health in a research report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price target on the stock. Citigroup boosted their price target on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Finally, TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th.

Read Our Latest Stock Report on CAH

Cardinal Health Stock Down 0.3 %

Shares of CAH stock opened at $126.35 on Friday. The stock has a 50-day moving average price of $122.85 and a 200 day moving average price of $116.30. The firm has a market cap of $30.52 billion, a price-to-earnings ratio of 23.57, a PEG ratio of 1.49 and a beta of 0.63. Cardinal Health has a 12 month low of $93.17 and a 12 month high of $132.84.

Cardinal Health (NYSE:CAHGet Free Report) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Sell-side analysts predict that Cardinal Health will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.60%. Cardinal Health’s payout ratio is 37.69%.

Institutional Trading of Cardinal Health

Several institutional investors and hedge funds have recently modified their holdings of the business. Good Life Advisors LLC increased its holdings in Cardinal Health by 96.0% in the 3rd quarter. Good Life Advisors LLC now owns 6,100 shares of the company’s stock worth $674,000 after purchasing an additional 2,987 shares in the last quarter. Bleakley Financial Group LLC increased its holdings in Cardinal Health by 6.4% in the 3rd quarter. Bleakley Financial Group LLC now owns 4,497 shares of the company’s stock worth $497,000 after purchasing an additional 272 shares in the last quarter. V Square Quantitative Management LLC increased its stake in shares of Cardinal Health by 8.1% in the third quarter. V Square Quantitative Management LLC now owns 3,361 shares of the company’s stock valued at $371,000 after buying an additional 253 shares during the period. Stonegate Investment Group LLC increased its stake in shares of Cardinal Health by 79.4% in the third quarter. Stonegate Investment Group LLC now owns 3,883 shares of the company’s stock valued at $429,000 after buying an additional 1,718 shares during the period. Finally, Blue Trust Inc. increased its stake in shares of Cardinal Health by 61.9% in the third quarter. Blue Trust Inc. now owns 5,503 shares of the company’s stock valued at $608,000 after buying an additional 2,103 shares during the period. 87.17% of the stock is currently owned by institutional investors.

About Cardinal Health

(Get Free Report

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.